Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
Steven E. Schild, Xiaofei Wang, Christine M. Bestvina, Terence M. Williams, Greg Masters, Anurag Kumar Singh, Thomas E. Stinchcombe, Joseph K. Salama, Steven Wolf, Tyler Zemla, Narjust Duma, Stephen G. Chun, Arya Amini, David Kozono, Colleen Watt
Topics & Concepts
MedicineLung cancerImmunotherapyOncologyInternal medicineSystemic therapyRandomized controlled trialCancerBreast cancerCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations